… These findings indicate that MAIT cells are engaged in the immune response against
SARS-CoV-2 and suggest their possible involvement in COVID-19 immunopathogenesis. Chronic …

… COVID-19 and IMTX-related toxicities. We performed a systematic review of the clinical trials
testing anti-inflammatory therapies … involved in the pathogenesis of COVID-19, especially by …

… the immunopathogenesis of COVID-19 and its implications for current efforts to develop
immune-based therapies … for current efforts to develop immune-based therapies and vaccines. …

… nant interferon application in the initial stage of disease, anticytokine therapy at the …
COVID19, но могут встречаться и при других тяжелых формах ОРВИ. Заподозрить COVID-19 …

… immune response, to explain the immunopathogenesis of COVID-19. We also propose
potential … for COVID-19 patients and present possible opportunities for therapeutic intervention. …

… successfully combat COVID-19, since no single therapy has … investigated against COVID-19
and will be reviewed herein. … -2, as well as therapeutic options and vaccines that are under …

… With the objective of linking early findings relating to the novel SARS-CoV-2 coronavirus …
therapeutic response, a coherent cellular and molecular pathway is proposed for COVID-19. …

… in the immunopathogenesis of COVID-19 [87]. Hence, anti-GM-CSF therapy has been used
to hospitalized severe COVID-19 … the efficacy of GM-CSF blockade for COVID-19 [87]. In the …

… of patients with COVID-19 and ARDS … of COVID-19 and the potential therapeutic benefits
of Treg.Bello et al observed that the number of Treg cells in SOT patients with severe COVID-19 …

… COVID-19 will be a crucial challenge to better address more effective therapeutic strategies.
… immune response can likely contribute to the immunopathogenesis of COVID-19 (Fig 2). Of …